maxillary sinus odontogenic keratocyst in a 19-year-old male with a history of an unrepaired orbital floor fracture. METHOD: Case report and literature review. RESULTS: A 19-year-old male with a history of an unrepaired right orbital floor fracture presented with diplopia, right periorbital swelling and retroorbital pain, as well as progressive swelling of the right cheek; all following a two-week prodrome of rhinorrhea, congestion, and fevers. In the emergency department, the patient required a lateral canthotomy due to increased intraocular pressure and diminished visual acuity. Primary drainage of the maxillary sinus was performed in the emergency department as well, yielding 25 ccs of purulent material with immediate resolution of the increased intraocular pressure. CT scan of facial bones revealed an unerupted molar tooth within the right maxillary sinus, associated with a cystic lesion occupying the entire sinus cavity, with an abscess extending into the right orbit through a previously unrepaired orbital floor. The patient was subsequently treated with intravenous antibiotics for 3 weeks and oral antibiotics until definitive surgery two months later. A combination of a Caldwell-Luc and an endoscopic approach were used to excise the contents of the right maxillary sinus. Final pathology revealed odontogenic keratocyst, encompassing a molar tooth. CONCLUSION: Odontogenic cysts rarely present with orbital manifestations. However they should not be excluded from the differential diagnosis, especially with a history orbital floor trauma.
Orbital Inflammatory Pseudotumor with Buccal Space Extension
Stanley Chia, MD (presenter); Larissa Sweeny OBJECTIVE: 1) Provide an understanding of inflammatory pseudotumor. 2) Discuss the histopathologic characteristics of inflammatory pseudotumor. 3) To present a rare case of inflammatory pseudotumor of the orbit with buccal space extension and discuss appropriate evaluation and treatment options. METHOD: Retrospective chart review and review of the relevant literature. The study was performed from August 2009 -March 2010.
RESULTS:
A 31 year old female presented with a one month history of orbital pain and visual changes. On examination, she was noted to have a 2 cm right buccal mass as well as right eye proptosis and diplopia affecting right lateral and vertical gaze. CT and MRI imaging revealed a 4.0 cm right intraconal mass with extension into the right buccal space. Biopsies from the buccal space and the orbit were histologically consistent with inflammatory pseudotumor. The patient was treated with corticosteroids with clinical improvement. CONCLUSION: Orbital inflammatory pseudotumors are typically confined to the orbit, and rarely extend into tissues of the head and neck. These lesions typically resolve with corticosteroids, but rarely, external beam radiation and cytotoxic agents are used for treatment failure. Aggressive forms of inflammatory pseudotumor histologically contain plasma cells that demonstrate the IgG4 phenotype. In cases of orbital inflammatory pseudotumor that extend to more accessible anatomic locations; these locations may be biopsied to obtain a definitive diagnosis with less potential for morbidity.
OSAHS in Patients with Nasopharyngeal Carcinoma
Michael Friedman, MD (presenter); Tanya Pulver, MD OBJECTIVE: Study the incidence of obstructive sleep apnea/ hypopnea syndrome (OSAHS) and changes in sleep architecture in patients with nasopharyngeal carcinoma (NPC) before and after treatment. METHOD: Subjects included adult (age Ͼ18 years) NPC patients with no prior history of upper airway surgery. Polysomnography (PSG) was performed prior to and 6 months after chemoradiation treatment for NPC. Epworth Sleepiness Scale (ESS) and bed-partner assessment of snoring on a 10point Visual Analog Scale (VAS) were collected before and 6 months after treatment. Wilcoxon signed rank test was used for statistical analysis. RESULTS: Twelve NPC patients (9 men, 3 women; mean, 49.5 years) were included. The incidence of OSAHS decreased from 83.3% (10/12) pre-treatment to 66.7% (8/12) after treatment. Mean decrease in the apnea/hypopnea index (AHI) was from 26.2ϩ-26.3 to 17.6ϩ-23.4 (p ϭ 0.092). AHI decreased in 9 patients (75%). Lowest oxygen saturation (%) increased from 80.4ϩ-13.9 to 86.0ϩ-12.1 (p ϭ 0.183). The light sleep stage (S1ϩS2, %) changed from 77.4ϩ-8.5 to 87.2ϩ-9.6 (pϭ 0.043). The rapid eye movement stage (%) decreased from 19.0ϩ-6.3 to 11.3ϩ-8.5 (p ϭ 0.052). ESS decreased from 12.0ϩ-5.6 to 8.3ϩ-3.4 (p ϭ 0.051). VAS for snoring decreased from 5.7ϩ-3.5 to 2.3ϩ-2.4 (p ϭ 0.001). CONCLUSION: The incidence of OSAHS was high among NPC patients included in this study. While AHI and lowest oxygen saturation improved following treatment for NPC, sleep architecture was adversely affected. Identification and treatment of OSAHS may be important for improving the quality of life patients with NPC.
Osteogenic Potential of Cells Derived From Nasal Septum
Chiara Bianchini, MD (presenter); Antonio Pastore, MD; Elena Torreggiani, BS; Elisabetta Lambertini, BS; Roberta Piva, BS OBJECTIVE: This research addresses new molecular targets detection, and the development of therapeutic strategies aimed to repair or replace damaged bone tissues in large expansion. The aim of this study was to determine the potential osteogenic P169 Poster Presentations POSTERS activity of bone cells from nasal septum and their use to perform accurate molecular analysis from a single sample. METHOD: The cells, collected during nasal septum surgery (from a total of 81 patients), were subsequently subjected to gene silencing, Reverse Transcriptase Polymerase Chain reactions, immunocytochemistry, and Chromatin Immunoprecipitation experiments. RESULTS: The cells gave rise to mature osteoblasts expressing osteogenic markers (ALP, Runx2, Slug) and were able to mineralize. For the first time, we demonstrated that Runx2, a marker of early osteospecific differentiation, interacts in vivo with promoter of SLUG gene, a marker of osteoblast maturation, indicating an important correlation between the pathways mediated by these two transcription factors. CONCLUSION: We demonstrated that nasal septum-derived osteoblasts can be an ideal, unique, easily accessible, noncontroversial alternative source for osteoblasts, due to the simple collection procedure during nasal septum surgery once bone tissue is routinely discharged. The ability to proliferate and to differentiate into mature osteoblasts at the same time, makes the use of these cells particularly attractive both for the research addressed to new molecular targets detection, and the development of therapeutic strategies aimed to repair and replace damaged tissues. At the same time, we demonstrated that, from a single sample, it is possible to obtain a sufficient quantity to perform several molecular analysis including RT-PCR, Chromatin immunoprecipitation, and immunocytochemical experiments.
Outpatient Bridging of Anticoagulation for Tonsillectomy
Adam Holdt, MD (presenter); Julie Goddard, MD OBJECTIVE: Tonsillectomy, with its unique risk of primary and secondary hemorrhage, is rarely performed in patients on long-term warfarin anticoagulation. The objectives of this study are to review the literature regarding management of perioperative anticoagulation therapy and to present an outpatient strategy of perioperative anticoagulation bridging for tonsillectomy using low molecular weight heparin (LMWH). METHOD: A literature search regarding guidelines for perioperative anticoagulation was performed. A case report is presented of a 29-year-old male on chronic warfarin for a mechanical mitral valve who underwent tonsillectomy. The patient has a history of mitral valve replacement due to endocarditis after an episode of Streptococcal tonsillitis. The patient's perioperative anticoagulation plan utilized LMWH therapy. He stopped warfarin and began LMWH five days prior to surgery, holding this 24 hours prior to surgery. He resumed LMWH postoperative day 3 and warfarin postoperative day 7, continuing both until reaching therapeutic INR. RESULTS: Tonsillectomy in an anticoagulated patient has previously been described once, and there are no guidelines for perioperative anticoagulation for this procedure. This patient managed his anticoagulation from home and successfully underwent surgery. He did not experience adverse events, did not require an extended inpatient stay, and is doing well 3 months postoperatively. CONCLUSION: Tonsillectomy can be performed successfully in an anticoagulated patient with outpatient LMWH bridging. A strategy for perioperative anticoagulation that accounts for the risk of secondary bleeding after tonsillectomy should be utilized. A larger cohort of patients would help elucidate the risk of adverse events with tonsillectomy in this patient population.
Postoperative Hemorrhage Following Coblation Tonsillectomy
Jason Siew Yoong Hwang, MBBS, FRCS (presenter) OBJECTIVE: This study aims: 1) To review the incidence of postoperative hemorrhage following coblation tonsillectomy.
2) To determine the correlation between surgeon grade and bleeding rates. 3) To determine if surgical time and postoperative hemorrhage are reduced after increased experience with coblation. METHOD: A retrospective review of 324 consecutive adult coblation tonsillectomies performed from January 2004 to December 2008 was done to assess for postoperative bleeding. Bleeding was divided into primary and secondary hemorrhage, then subanalyzed by surgeon grade (consultant, senior resident and junior resident). Surgical time was also reviewed. RESULTS: The postoperative hemorrhage rate for coblation tonsillectomy was 11.4% (37/324). Of these 37 cases, there were 6 primary bleeds and 31 secondary bleeds. Majority of these episodes resolved with conservative treatment. Only 6 cases (1.9%) required hemostasis under general anesthesia. Junior residents had the highest overall postoperative hemorrhage rate amongst the surgeons(17.4%). Subanalysis showed consultants had the highest proportion of primary bleeds (4 of 6 cases) whilst senior residents had the highest proportion of secondary bleeds (15 of 31 cases). Analysis by year did not show any significant trend in postoperative hemorrhage rates (pϭ .87). No reduction in average operating time was observed over the 5 year review period (pϭ.98). CONCLUSION: Our postoperative hemorrhage rate of 11.4% is comparable with recent literature. A higher proportion of cases performed by junior surgeons developed postoperative bleeding. We believe this is due to limited exposure and training with coblation. Increased experience with coblation does not translate into faster operating time.
Proinflammatory Mediator and EMT in HNSCC
Jun Kim, MD (presenter) OBJECTIVE: Various proinflammatory mediators contribute to tumor proliferation, neoangiogenesis, tumor invasion and
